RNA, U6 small nuclear 1179, pseudogene (RNU6-1179P)

RNU6-1179P is classified as a pseudogene of the U6 small nuclear RNA gene family, annotated as "RNA, U6 small nuclear 1179, pseudogene." Pseudogenes are defective gene copies that have lost their protein-coding or functional RNA capacity due to disabling mutations or other evolutionary events such as duplication or retrotransposition[5][8]. The U6 snRNA gene encodes a non-coding RNA component of the spliceosome complex, critical in mRNA splicing[1][3]. However, as a pseudogene, RNU6-1179P does not produce functional U6 snRNA and has no known biological function or clinical relevance; it is merely a remnant of an ancestral duplication or retrotransposition event[5][7][8]. Pseudogenes are not considered therapeutic targets since they are, by definition, non-functional and not actively involved in canonical cellular processes or disease mechanisms[5][8]. There are no known protein products, diseases, biomarkers, drugs, or safety issues associated with RNU6-1179P. Summary: RNU6-1179P is a non-functional, non-protein-coding pseudogene and is not a therapeutic target. It does not have known aliases beyond systematic pseudogene nomenclature, does not participate in molecular pathways, and is not associated with disease or drug response[2][5][8].

Other names

RNU6-1179PRNA, U6 small nuclear 1179, pseudogeneU6 snRNA pseudogene